RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $933,341 | -16.3% | 864,205 | 0.0% | 0.00% | – |
| Q2 2023 | $1,114,824 | -2.5% | 864,205 | -0.2% | 0.00% | – |
| Q1 2023 | $1,143,536 | -4.8% | 866,315 | +8.2% | 0.00% | – |
| Q4 2022 | $1,201,046 | +16.9% | 800,697 | -7.9% | 0.00% | – |
| Q3 2022 | $1,027,000 | +4.7% | 869,594 | +0.3% | 0.00% | – |
| Q2 2022 | $981,000 | -62.3% | 867,350 | -0.4% | 0.00% | -100.0% |
| Q1 2022 | $2,604,000 | +16.6% | 870,693 | +3.3% | 0.00% | 0.0% |
| Q4 2021 | $2,234,000 | -26.2% | 842,931 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $3,027,000 | +63.2% | 833,873 | +95.1% | 0.00% | 0.0% |
| Q2 2021 | $1,855,000 | +25.8% | 427,312 | -0.8% | 0.00% | 0.0% |
| Q1 2021 | $1,474,000 | +1.0% | 430,913 | +3.3% | 0.00% | 0.0% |
| Q4 2020 | $1,460,000 | +51.9% | 417,133 | +4.2% | 0.00% | – |
| Q3 2020 | $961,000 | +26.0% | 400,311 | -4.0% | 0.00% | – |
| Q2 2020 | $763,000 | +21.3% | 416,793 | +3.4% | 0.00% | – |
| Q1 2020 | $629,000 | -27.1% | 403,104 | -0.0% | 0.00% | – |
| Q4 2019 | $863,000 | +14.3% | 403,243 | 0.0% | 0.00% | – |
| Q3 2019 | $755,000 | -28.3% | 403,243 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $1,053,000 | +8.2% | 403,243 | +6.6% | 0.00% | 0.0% |
| Q1 2019 | $973,000 | +15.1% | 378,254 | +3.0% | 0.00% | 0.0% |
| Q4 2018 | $845,000 | -28.3% | 367,231 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $1,179,000 | +17.1% | 367,231 | +3.2% | 0.00% | 0.0% |
| Q2 2018 | $1,007,000 | -5.4% | 355,800 | +18.4% | 0.00% | 0.0% |
| Q1 2018 | $1,064,000 | -8.4% | 300,500 | +0.4% | 0.00% | 0.0% |
| Q4 2017 | $1,161,000 | +70.5% | 299,200 | +11.6% | 0.00% | 0.0% |
| Q3 2017 | $681,000 | -7.0% | 268,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $732,000 | -17.6% | 268,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $888,000 | +85.0% | 268,000 | +32.9% | 0.00% | 0.0% |
| Q4 2016 | $480,000 | -35.1% | 201,600 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $740,000 | +64.4% | 201,600 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $450,000 | +7.1% | 201,600 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $420,000 | -31.3% | 201,600 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $611,000 | +22.7% | 201,600 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $498,000 | -23.1% | 201,600 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $648,000 | -38.6% | 201,600 | -31.7% | 0.00% | 0.0% |
| Q1 2015 | $1,055,000 | +57.2% | 295,349 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $671,000 | +15.9% | 295,349 | -0.9% | 0.00% | 0.0% |
| Q3 2014 | $579,000 | -57.0% | 298,110 | -19.6% | 0.00% | -50.0% |
| Q2 2014 | $1,347,000 | +44.1% | 370,959 | +53.9% | 0.00% | 0.0% |
| Q1 2014 | $935,000 | +39.3% | 240,969 | +2.4% | 0.00% | +100.0% |
| Q4 2013 | $671,000 | -18.5% | 235,269 | +3.0% | 0.00% | -50.0% |
| Q3 2013 | $823,000 | +25.8% | 228,429 | +17.4% | 0.00% | +100.0% |
| Q2 2013 | $654,000 | – | 194,565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |